Target gene	Representative transcript	Gene name	3P-seq tags + 5	Conserved sites total	Conserved 8mer sites	Conserved 7mer-m8 sites	Conserved 7mer-A1 sites	Poorly conserved sites total	Poorly conserved 8mer sites	Poorly conserved 7mer-m8 sites	Poorly conserved 7mer-A1 sites	6mer sites	Representative miRNA	Predicted occupancy (low miRNA)	Predicted occupancy (high miRNA)	Predicted occupancy (transfected miRNA)	Cumulative weighted context++ score	Total context++ score	Aggregate PCT	"Previous TargetScan publication(s)
"	
ZNF385D	ENST00000281523.2	zinc finger protein 385D 	5	1	0	0	1	4	1	1	2	1	hsa-miR-155-5p	0.0644	0.432	2.0814	-0.8	-0.8	0.64	"NULL
"	
TMPRSS11BNL	ENST00000432593.3	TMPRSS11B N-terminal like 	5	1	1	0	0	2	1	1	0	0	hsa-miR-155-5p	0.0559	0.3679	1.5556	-0.68	-0.68	0.24	2011	
VAV3	ENST00000370056.4	vav 3 guanine nucleotide exchange factor 	1128	1	1	0	0	1	1	0	0	0	hsa-miR-155-5p	0.0475	0.3167	1.4396	-0.64	-0.64	< 0.1	"2009, 2011
"	
ETS1	ENST00000531611.1	v-ets avian erythroblastosis virus E26 oncogene homolog 1 	1423	2	2	0	0	0	0	0	0	1	hsa-miR-155-5p	0.0448	0.2978	1.3124	-0.6	-0.64	0.52	"2005, 2007, 2009, 2011
"	
ACTA1	ENST00000366684.3	"actin, alpha 1, skeletal muscle "	14	1	1	0	0	0	0	0	0	0	hsa-miR-155-5p	0.0321	0.1984	0.6779	-0.59	-0.59	0.42	"2007, 2009, 2011
"	
ARID2	ENST00000457135.1	"AT rich interactive domain 2 (ARID, RFX-like) "	891	2	1	1	0	0	0	0	0	1	hsa-miR-155-5p	0.0725	0.4237	1.3887	-0.58	-0.58	0.71	"2005, 2007, 2009, 2011
"	
H3F3A	ENST00000366813.1	"H3 histone, family 3A "	15	1	1	0	0	0	0	0	0	0	hsa-miR-155-5p	0.0373	0.2277	0.7765	-0.58	-0.58	0.34	"2005, 2007, 2009, 2011
"	
ZNF652	ENST00000362063.2	zinc finger protein 652 	33	2	1	1	0	2	0	1	1	3	hsa-miR-155-5p	0.0887	0.5377	1.9777	-0.57	-0.7	0.93	"2005, 2007, 2009, 2011
"	
VMA21	ENST00000330374.6	VMA21 vacuolar H+-ATPase homolog (S. cerevisiae) 	2162	1	1	0	0	0	0	0	0	0	hsa-miR-155-5p	0.0483	0.2805	0.8614	-0.54	-0.54	< 0.1	"2009, 2011
"	
ACTL7A	ENST00000333999.3	actin-like 7A 	5	1	1	0	0	0	0	0	0	0	hsa-miR-155-5p	0.0393	0.2321	0.6907	-0.53	-0.53	< 0.1	"NULL
"	
TM6SF1	ENST00000379390.6	transmembrane 6 superfamily member 1 	211	1	1	0	0	0	0	0	0	0	hsa-miR-155-5p	0.0295	0.1834	0.624	-0.53	-0.53	< 0.1	"NULL
"	
CEBPB	ENST00000303004.3	"CCAAT/enhancer binding protein (C/EBP), beta "	3178	1	1	0	0	0	0	0	0	0	hsa-miR-155-5p	0.0533	0.29	0.7258	-0.52	-0.56	0.77	"2005, 2007, 2009, 2011
"	
FOS	ENST00000303562.4	FBJ murine osteosarcoma viral oncogene homolog 	3716	1	1	0	0	0	0	0	0	2	hsa-miR-155-5p	0.0882	0.4285	0.9782	-0.52	-0.55	0.55	"2009, 2011
"	
WWC1	ENST00000265293.4	WW and C2 domain containing 1 	43	1	1	0	0	0	0	0	0	0	hsa-miR-155-5p	0.0649	0.3518	0.9632	-0.52	-0.52	0.94	"2007, 2009, 2011
"	
TAOK1	ENST00000261716.3	TAO kinase 1 	164	1	0	0	1	2	0	0	2	1	hsa-miR-155-5p	0.0533	0.3744	2.0567	-0.51	-0.56	0.4	"NULL
"	
TMEM202	ENST00000341689.3	transmembrane protein 202 	5	1	1	0	0	1	0	1	0	0	hsa-miR-155-5p	0.0117	0.0802	0.3921	-0.5	-0.74	< 0.1	"2009, 2011
"	
TSHZ3	ENST00000240587.4	teashirt zinc finger homeobox 3 	81	3	1	0	2	0	0	0	0	0	hsa-miR-155-5p	0.0644	0.4039	1.5638	-0.5	-0.62	0.81	"2007, 2009, 2011
"	
ZIC3	ENST00000287538.5	Zic family member 3 	9	2	1	1	0	0	0	0	0	0	hsa-miR-155-5p	0.0517	0.3143	1.1001	-0.49	-0.49	0.62	"2005, 2007, 2009, 2011
"	
FBXO33	ENST00000298097.7	F-box protein 33 	306	1	1	0	0	0	0	0	0	0	hsa-miR-155-5p	0.0409	0.2429	0.7561	-0.48	-0.48	0.5	"2005, 2007, 2009, 2011
"	
DYNC1I1	ENST00000447467.2	"dynein, cytoplasmic 1, intermediate chain 1 "	25	1	1	0	0	0	0	0	0	0	hsa-miR-155-5p	0.0372	0.2253	0.7363	-0.48	-0.48	0.4	"2007, 2009, 2011
"	
CSNK1A1	ENST00000261798.5	"casein kinase 1, alpha 1 "	769	1	0	0	1	2	1	1	0	1	hsa-miR-155-5p	0.0394	0.2662	1.2402	-0.47	-0.68	0.72	"2005, 2007
"	
FGF7	ENST00000267843.4	fibroblast growth factor 7 	5	2	1	0	1	0	0	0	0	0	hsa-miR-155-5p	0.0616	0.3793	1.3041	-0.47	-0.47	0.96	"2005, 2007, 2009, 2011
"	
GABRA1	ENST00000428797.2	"gamma-aminobutyric acid (GABA) A receptor, alpha 1 "	5	1	1	0	0	2	0	2	0	1	hsa-miR-155-5p	0.0793	0.4899	1.8611	-0.46	-0.46	0.37	"2009, 2011
"	
CDX1	ENST00000231656.8	caudal type homeobox 1 	5	1	1	0	0	0	0	0	0	0	hsa-miR-155-5p	0.0171	0.1142	0.4879	-0.46	-0.46	< 0.1	"2009, 2011
"	
CARHSP1	ENST00000396593.2	"calcium regulated heat stable protein 1, 24kDa "	113	1	1	0	0	0	0	0	0	1	hsa-miR-155-5p	0.0377	0.2263	0.7112	-0.46	-0.49	0.52	"2005, 2007, 2009, 2011
"	
TCF4	ENST00000354452.3	transcription factor 4 	394	3	2	1	0	1	0	1	0	0	hsa-miR-155-5p	0.0726	0.4732	1.9429	-0.46	-0.48	0.62	"2009, 2011
"	
RNF123	ENST00000327697.6	ring finger protein 123 	85	1	1	0	0	0	0	0	0	0	hsa-miR-155-5p	0.0352	0.2119	0.6583	-0.46	-0.47	0.36	"2005, 2007, 2009, 2011
"	
DET1	ENST00000564406.1	de-etiolated homolog 1 (Arabidopsis) 	5	1	1	0	0	1	0	1	0	1	hsa-miR-155-5p	0.0208	0.1443	0.7488	-0.45	-0.45	0.23	"2009, 2011
"	
CYB561D1	ENST00000496961.1	"cytochrome b561 family, member D1 "	105	1	1	0	0	0	0	0	0	0	hsa-miR-155-5p	0.0346	0.2088	0.6625	-0.45	-0.48	0.34	2011	
JARID2	ENST00000341776.2	"jumonji, AT rich interactive domain 2 "	199	2	2	0	0	0	0	0	0	0	hsa-miR-155-5p	0.0746	0.4442	1.3575	-0.45	-0.45	0.82	"2009, 2011
"	
MBNL3	ENST00000370839.3	muscleblind-like splicing regulator 3 	593	1	1	0	0	1	0	1	0	1	hsa-miR-155-5p	0.0389	0.2544	1.1	-0.44	-0.48	< 0.1	2011	
NDFIP1	ENST00000253814.4	Nedd4 family interacting protein 1 	2478	1	1	0	0	1	0	0	1	1	hsa-miR-155-5p	0.038	0.2295	0.7436	-0.44	-0.68	0.11	"2005, 2007, 2011
"	
TCF7L2	ENST00000369386.1	"transcription factor 7-like 2 (T-cell specific, HMG-box) "	650	1	1	0	0	1	0	0	1	0	hsa-miR-155-5p	0.0423	0.2657	0.9939	-0.44	-0.45	0.23	2011	
G2E3	ENST00000206595.6	G2/M-phase specific E3 ubiquitin protein ligase 	286	1	1	0	0	1	0	1	0	0	hsa-miR-155-5p	0.0557	0.341	1.1721	-0.43	-0.48	0.53	"2009, 2011
"	
C3orf18	ENST00000426034.1	chromosome 3 open reading frame 18 	29	1	1	0	0	0	0	0	0	0	hsa-miR-155-5p	0.0293	0.1821	0.622	-0.43	-0.43	0.47	"2005, 2007, 2009, 2011
"	
RPS6KB1	ENST00000225577.4	"ribosomal protein S6 kinase, 70kDa, polypeptide 1 "	16	1	0	1	0	1	1	0	0	1	hsa-miR-155-5p	0.0379	0.2512	1.1272	-0.43	-0.43	0.23	"NULL
"	
SPI1	ENST00000533030.1	spleen focus forming virus (SFFV) proviral integration oncogene 	5	1	1	0	0	0	0	0	0	0	hsa-miR-155-5p	0.017	0.1136	0.4864	-0.43	-0.43	< 0.1	"2005, 2007, 2009, 2011
"	
WEE1	ENST00000299613.6	WEE1 homolog (S. pombe) 	331	1	1	0	0	0	0	0	0	0	hsa-miR-155-5p	0.0676	0.3477	0.8037	-0.43	-0.44	0.94	"2005, 2007, 2009, 2011
"	
BACH1	ENST00000286800.3	"BTB and CNC homology 1, basic leucine zipper transcription factor 1 "	273	3	1	2	0	1	0	1	0	0	hsa-miR-155-5p	0.0929	0.5633	2.0064	-0.42	-0.44	0.79	"2005, 2007, 2009, 2011
"	
PICALM	ENST00000532317.1	phosphatidylinositol binding clathrin assembly protein 	1173	1	0	1	0	2	0	1	1	1	hsa-miR-155-5p	0.0305	0.2124	1.1264	-0.42	-0.42	0.61	"2005, 2007
"	
CD274	ENST00000381573.4	CD274 molecule 	351	1	0	0	1	1	0	1	0	0	hsa-miR-155-5p	0.0316	0.2117	0.9375	-0.41	-0.43	0.65	2011	
RGP1	ENST00000378078.4	RGP1 retrograde golgi transport homolog (S. cerevisiae) 	203	1	1	0	0	0	0	0	0	1	hsa-miR-155-5p	0.0707	0.3589	0.8181	-0.41	-0.43	0.37	"NULL
"	
HNRNPA3	ENST00000411529.2	heterogeneous nuclear ribonucleoprotein A3 	329	2	1	1	0	1	0	0	1	1	hsa-miR-155-5p	0.0376	0.2343	0.8692	-0.41	-0.57	0.44	"2007, 2009, 2011
"	
HERC4	ENST00000277817.6	HECT and RLD domain containing E3 ubiquitin protein ligase 4 	1138	1	1	0	0	0	0	0	0	0	hsa-miR-155-5p	0.0195	0.1328	0.6384	-0.41	-0.41	0.21	"2009, 2011
"	
BRWD3	ENST00000373275.4	bromodomain and WD repeat domain containing 3 	506	1	0	0	1	1	0	0	1	0	hsa-miR-155-5p	0.0536	0.3475	1.4561	-0.41	-0.41	0.75	2011	
TP53INP1	ENST00000448464.2	tumor protein p53 inducible nuclear protein 1 	39	1	1	0	0	0	0	0	0	0	hsa-miR-155-5p	0.0577	0.3027	0.7552	-0.41	-0.5	0.57	"2005, 2007, 2009, 2011
"	
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
																					
